Publications
Gordon CE, Uhlig K, Lau J, Schmid CH, Levey AS, Wong JB. Interferon treatment in hemodialysis patients with chronic hepatitis C virus infection: a systematic review of the literature and meta-analysis of treatment efficacy and harms. American Journal of Kidney Disease 2008;51(2):263-77.
Stahl JE, Tramantano AC, Swann JS, Cohen BJ. Balancing urgency, age and quality of life in organ allocation decisions - What would you do? a survey. Journal of Medical Ethics 2008;34:109-115.
Concannon TW, Kent DM, Normand S, Newhouse JP, Griffith JL, Ruthazer R, Beshansky JR, Wong JB, Aversano T, Selker HP.A geospatial analysis of emergency transport and inter-hospital transfer in ST-segment myocardial infarction. American Journal of Cardiology 2008;101(1):69-74.
Kassirer JP. Assault on editorial independence: Improprieties of the Canadian Medical Association. Journal of Medical Ethics 2007;33:63-66.
Kassirer JP. Ghostwriters and ghostbusters. Trial. Journal of the American Association for Justice 2007; Sept:38-43.
Bischoff-Ferrari HA, Dawson-Hughes B, Baron JA, Burckhardt P, Li R, Spiegelman D, Specker B, Orav JE, Wong JB, Staehelin HB, O'Reilly E, Kiel DP, Willett WC. Calcium intake and hip fracture risk in men and women: a meta-analysis of prospective cohort studies and randomized controlled trials. American Journal of Clinical Nutrition 2007;86(6):1780-90.
Kassirer JP. Medical classics: The Plague. BMJ 2007;335:567.
Rajendra A, Wong JB.Economics of chronic hepatitis B and hepatitis C. Journal of Hepatology 2007;47(4):608-17.
Dansinger ML, Tatsioni A, Wong JB, Chung M, Balk EM.The effect of dietary counseling for weight loss: A systematic review with meta-analysis. Annals of Internal Medicine 2007;146(1):41-50.
McHutchison JG, Manns MP, Brown Jr RS, Reddy KR, Shiffman ML, Wong JB.Strategies for managing anemia in hepatitis C patients undergoing antiviral therapy. American Journal of Gastroenterology 2007;102(4):880-9.
Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A.Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. Journal of Bone and Mineral Research 2007;22(3):465-75.
Deuffic-Burban S, Poynard T, Sulkowski MS, Wong JB.Estimating the future health burden of chronic hepatitis C and human immunodeficiency virus infections in the United States. Journal of Viral Hepatitis 2007;14(2):107-15.
Liem YS, Wong JB, Hunink, MGM, de Charro FT, Winkelmayer WC.Comparison of hemodialysis and peritoneal dialysis survival in the Netherlands. Kidney International 2007;71(2):153-8.
Sondhi M, Jagannath A, Wong JB.A meta-analysis of randomized controlled trials with coronary drug-eluting stents compared with bare-metal stents. Internet Journal of Cardiology 2006;3(2) http://www.ispub.com/ostia/index.php?xmlPrinter=true&xmlFilePath=journals/ijc/vol3n2/des.xml.
Shah BB, Wong JB.The economics of hepatitis C virus. Clinics in Liver Disease 2006;10:717-34.
Wong JB.Hepatitis C: Cost of illness and considerations for the economic evaluation of anti-viral therapies PharmacoEconomics 2006;24(7):661-72.
Robinson D Jr, Hackett M, Wong J, Kimball A, Cohen R, Bala M.Co-occurrence and comorbidities in patients with immune-mediated inflammatory disorders: an exploration using US healthcare claims data, 2001-2002. Current Medical Research and Opinion 2006;22(5):989-1000.
Pauker SG, Wong JB.The influence of influence diagrams in medicine. Decision Analysis 2005;2(4)238-44.
Wasem J, Sroczynski G, Aidelsburger P, Buchberger B, Hessel1 F, Conrads-Frank A, Peters-Blöchinger A, Kurth BM, Wong JB, Rossol S, Siebert U.Gesundheitsökonomische Aspekte chronischer Infektionskrankheiten am Beispiel der chronischen Hepatitis C. Bundesgesundheitsbl - Gesundheitsforsch - Gesundheitsschutz 2006;49(1);57-63.
Golan Y, Wolf MP, Pauker SG, Wong JB, Hadley S. Empirical anti-Candida therapy among selected patients in the intensive care unit: a cost-effectiveness analysis. Annals of Internal Medicine 2005;143(12):857-69.
Drummond MF, Barbieri M, Wong JB.Analytic choices in economic models of treatments for rheumatoid arthritis: what makes a difference? Medical Decision Making 2005;25(5):520-33.
Braithwaite RS, Justice AC, Chang CH, Fusco JS, Raffanti SR, Wong JB, Roberts MS.Estimating the proportion of patients infected with HIV who will die of comorbid diseases. American Journal of Medicine 2005;118(8):890-8.
Barbieri M, Wong JB, Drummond M.The cost-effectiveness of infliximab for severe treatment-resistant rheumatoid arthritis in the UK. PharmacoEconomics 2005;23(6):607-18.
Johnston JA, Brill-Edwards P, Ginsberg JS, Pauker SG, Eckman MH.Cost-effectiveness of prophylactic low molecular weight heparin in pregnant women with a prior history of venous thromboembolism. American Journal of Medicine 2005;118(5):503-14.
Pauker SG, Estes NA, Salem DN.Preventing sudden cardiac death: can we afford the benefit? Annals of Internal Medicine 2005;142(8):664-6.
Noguchi Y, Nagata-Kobayashi S, Stahl JE, Wong JB.A meta-analytic comparison of echocardiographic stressors. The International Journal of Cardiovascular Imaging 2005;21(2-3):189-207.
Siebert U, Sroczynski G, Wasem J, Greiner W, Ravens-Sieberer U, Aidelsburger P, Kurth BM, Bullinger M, Graf von der Schulenburg JM, Wong JB, Rossol S.Using competence network collaboration and decision-analytic modeling to assess the cost-effectiveness of interferon alpha-2b plus ribavirin as initial treatment of chronic hepatitis C in Germany. European Journal of Health Economics 2005;6(2):112-23.
Bischoff-Ferrari HA, Willett WC, Wong JB, Giovannucci E, Dietrich T, Dawson-Hughes B.Fracture prevention with vitamin D supplements. A meta-analysis of randomized controlled trials. JAMA 2005;293(18):2257-64.
Sondhi M, Goffin JR, Cohen BJ, Wong JB, Pauker SG.DEALE-ing with lung cancer and heart failure. Medical Decision Making 2005;25(1):82-94.
Amin MG, Wolf MP, TenBrook JA Jr, Freeman RB Jr, Cheng SJ, Pratt DS, Wong JB.Expanded criteria donor grafts for deceased donor liver transplantation under the MELD System: a decision analysis. Liver Transplantation 2004;10(12):1468-75.
Wong JB. Cost-effectiveness of anti-tumor necrosis factor agents. Clinical and Experimental Rheumatology 2004;22(Suppl 35):S-29-34.
Elstein AS, Fryback DG, Weinstein MC, Pauker SG, Holmes-Rovner M, Young MJ, Barry MJ, Eckman MH, Hunink MGM, Tsevat J, Wong JB. Presidential reflections on the 25th anniversary of the Society for Medical Decision Making. Medical Decision Making 2004;24(4):408-20.
Salem DN, Stein PD, Al-Ahmad A, Bussey HI, Horstkotte D, Miller N, Pauker SG.Antithrombotic therapy in valvular heart disease--native and prosthetic: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126(3 Suppl):457S-482S.
TenBrook JA Jr, Wolf MP, Hoffman SN, Rosenwasser LJ, Konstam MA, Salem DN, Wong JB.Should beta-blockers be given to patients with heart disease and peanut-induced anaphylaxis? A decision analysis. Journal of Allergy and Clinical Immunology 2004;113(5)977-82.
Rothberg M, Wong JB.All dysuria is local: a cost-effectiveness model for designing site-specific management algorithms. Journal of General Internal Medicine 2004;19(5pt1):433-43.
Ishida H, Inoue Y, Wong JB, Okita K. Cost-effectiveness of ribavirin plus interferon alpha-2b for either interferon relapsers or non-responders in chronic hepatitis C: a Japanese trial. Hepatology Research 2004;28(3)125-36.
TenBrook JA Jr, Iafrati MD, O'Donnell TF Jr, Wolf MP, Hoffman SN, Pauker SG, Lau J, Wong JB.Systematic review of outcomes after surgical management of venous disease incorporating subfascial endoscopic perforator surgery. Journal of Vascular Surgery 2004;39(3):583-9.
Fine AM, Wong JB, Fraser HSF, Fleisher GR, Mandl KD.Is it influenza or anthrax? a decision analytic approach to the management of patients with influenza-like illnesses. Annals of Emergency Medicine 2004;43(3):318-28.
Deuffic-Burban S, Wong JB, Valleron AJ, Costagliola D, Delfraissy JF, Poynard T.Comparing the public health burden of chronic hepatitis C and HIV infection in France. Journal of Hepatology 2004;40(2):319-26.
Marshall DA, Kleinman SH, Wong JB, AuBuchon JP, Grima DT, Kulin NA, Weinstein MC.Cost-effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C, and human immunodeficiency virus in the United States. Vox Sanguinis 2004;86(1):28-40.
Krahn M, Wong JB, Heathcote J, Scully L, Seeff L.Estimating the prognosis of hepatitis C patients infected by transfusion in Canada between 1986 and 1990. Medical Decision Making 2004;24(1):20-9.
Col NF, Pauker SG.The Discrepancy between observational studies and randomized trials of menopausal hormone therapy: Did expectations shape experience? Annals of Internal Medicine 2003;139(11):923-9.
Wong JB, Davis GL, McHutchison JG, Manns MP, Albrecht JK, for the International Hepatitis Interventional Therapy (IHIT) Group.Economic and clinical effects of evaluating rapid virological response to peginterferon alfa-2b plus ribavirin for the initial treatment of chronic hepatitis C. American Journal of Gastroenterology 2003;98(11):2354-62.
Davis GL, Wong JB, McHutchison JG, Manns MP, Harvey J, Albrecht J. Early virologic response to treatment with pegylated interferon alfa-2b plus ribavirin in patients with chronic hepatitis C. Hepatology 2003;38(3):645-52.
Hoffman SN, Tenbrook JA Jr, Wolf MP, Pauker SG, Salem DN, Wong JB.A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: one- to eight-year outcomes. Journal of the American College of Cardiology 2003;41(8)1293-304.
Maetzel A, Tugwell P, Boers M, Guillemin F, Coyle D, Drummond M, Wong JB, Gabriel SE.Economic evaluation of programs or interventions in the management of rheumatoid arthritis: Defining a consensus-based reference case. Journal of Rheumatology 2003;30(4):891-6.
Buti M, Medina M, Casado MA, Wong JB, Fosbrook L, Esteban R.A cost-effectiveness analysis of peginterferon alfa-2b plus ribavirin for the treatment of naive patients with chronic hepatitis C. Alimentary Pharmacology and Therapeutics 2003;17(5):687-94.
Salem DN. Pauker SG.The adverse effects of HIPAA on patient care. New England Journal of Medicine 2003;349(3):309.
Siebert U, Sroczynski G, Rossol S, Wasem J, Ravens-Sieberer U, Kurth BM, Manns MP, McHutchison JG, Wong JB, German Hepatitis C Model (GEHMO) Group, International Hepatitis Interventional Therapy Group.Cost-effectiveness of peginterferon alfa-2b plus ribavirin versus interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C. Gut 2003;52(3):425-32.
Braithwaite RS, Col NF, Wong JB.Estimating hip fracture morbidity, mortality and costs. Journal of the American Geriatrics Society 2003;51(3):364-70.
Wong JB, Singh G, Kavanaugh A.Estimating the cost-effectiveness of 54 weeks of infliximab for rheumatoid arthritis. American Journal of Medicine 2002;113(5):400-8.
Wong JB. Nevens F.Cost-effectiveness of peginterferon alfa-2b plus ribavirin compared to interferon alfa-2b plus ribavirin as initial treatment of chronic hepatitis C in Belgium. Acta Gastroenterologica Belgica 2002;65(2):110-11.
Wong JB.Pharmacogenomics of hepatitis C and decision analysis: a glimpse into the future. Hepatology 2002;36(1):252-4.
Cheng SJ, Freeman RB Jr, Wong JB.Predicting the probability of progression-free survival in patients with small hepatocellular carcinoma. Transplantation 2002;8(4);323-8.
Rothberg M, Bennish ML, Kao JS, Wong JB.Do the benefits from varicella vaccination outweigh the long-term risks? a decision-analytic model for policymakers and pediatricians. Clinical Infectious Disease 2002;99(7):885-94.
Eckman MH, Singh SK, Erban JK, Kao G.Testing for Factor V Leiden in patients with pulmonary or venous thromboembolism: a cost-effectiveness analysis. Medical Decision Making 2002;22(2):108-24.
Stein K, Rosenberg W, Wong J.Cost effectiveness of combination therapy for hepatitis C: a decision analytic model. Gut 2002;50(2):253-8.
de Vries SO, Visser K, de Vries JA, Wong JB, Donaldson MC, Hunink MGM.Cost-effectiveness of revascularization versus exercise therapy in patients with intermittent claudication. Radiology 2002;222(1):25-36.
Sagmeister M, Renner EL, Mullhaupt B, Wong JB. Simulation of hepatitis C based on a mandatory reporting system. European Journal of Gastroenterology & Hepatology 2002;14(1):25-34.
Wong JB, Ramey DR, Singh G.Long-term morbidity, mortality and economics of rheumatoid arthritis. Arthritis & Rheumatism 2001;44(12):2746-9.
Balk EM, Zucker DR, Engels EA, Wong JB, Williams JW Jr, Lau J.Strategies for diagnosing and treating acute bacterial sinusitis: a cost-effectiveness analysis. Journal of General Internal Medicine 2001;16(10):701-11.
Cheng SJ, Pratt DS, Freeman RB Jr, Kaplan MM, Wong JB.Living-donor versus cadaveric liver transplantation for non-resectable small hepatocellular carcinoma and compensated cirrhosis: a decision analysis. Transplantation 2001;72(5):861-8.
Sennfalt K, Reichard O, Hultkrantz R, Wong JB, Jonsson D.Cost-effectiveness of interferon alfa-2b with and without ribavirin as therapy for chronic hepatitis C in Sweden. Scandinavian Journal of Gastroenterology 2001;36(8):870-6
DeLong ER, Nelson CL, Wong JB, Pryor DB, Peterson ED, Lee KL, Mark DB, Califf RM, Pauker SG. Using observational data to estimate prognosis: an example using a coronary artery disease registry. Statistics in Medicine 2001;20(16):2505-32.
Sagmeister M, Wong JB, Mullhaupt B, Renner EL.A pragmatic and cost-effective strategy of a combination therapy of interferon alpha-2b and ribavirin for the treatment of chronic hepatitis C. European Journal of Gastroenterology & Hepatology 2001;13(5):483-8
Col NF, Hirota LK, Orr RK, Erban JK, Wong JB, Lau J.Hormone replacement therapy after breast cancer: a systematic review and quantitative assessment of risk. Journal of Clinical Oncology 2001; 19(8):2357-63
Sinclair JC, Cook RJ, Guyatt GH, Pauker SG, Cook DJ.When should an effective treatment be used? Derivation of the threshold number needed to treat and the minimum event rate for treatment. Journal of Clinical Epidemiology 2001;54(3):253-62.
Salem DN, Daudelin HD, Levine HJ, Pauker SG, Eckman MH, Riff J. Antithrombotic therapy in valvular heart disease. Chest 2001;119(1 Suppl):207S-219S
Pauker SG.A Society for Medical Decision Making. Medical Decision Making 2001;21(1):78-9.
Cheng SJ, Bonis PA, Lau J, Pham NQ, Wong JB.Interferon and ribavirin for patients with chronic hepatitis C who did not respond to previous IFN therapy: a meta-analysis of controlled and uncontrolled trials. Hepatology 2001;33(1):231-40.
Wong JB, Koff RS.Watchful waiting with periodic liver biopsy versus immediate empirical therapy for histololgically mild chronic hepatitis C. A cost-effectiveness analysis. Annals of Internal Medicine. 2000;133(9):665-75.
Wong JB, McQuillan GM, McHutchison JG, Poynard T.Estimating future hepatitis C morbidity, mortality, and costs in the United States. American Journal of Public Health. 2000;90(10):1562-9.
Katz D, Payne D, Pauker S.Early surgery versus conservative management of dissecting aneurysms of the descending thoracic aorta. Medical Decision Making 2000;20(4):377-393.
Buti, M, Casado, MA, Fosbrook L, Wong JB, Esteban R.Cost-effectiveness of combination therapy for naive patients with chronic hepatitis C. Journal of Hepatology. 2000;33(4):651-8.
Wong JB, Poynard T, Ling MH, Albrecht JK, Pauker SG.Cost-effectiveness of 24 or 48 weeks of interferon alpha-2b alone or with ribavirin as initial treatment of chronic hepatitis C. International Hepatitis Interventional Therapy Group. American Journal of Gastroenterology. 2000;95(6):1524-30.
Wong JB, Davis GL, Pauker SG.Cost effectiveness of ribavirin/interferon alfa-2b after interferon relapse in chronic hepatitis C. American Journal of Medicine. 2000;108(5):366-73.
Wong JB. Therapies in hepatitis C: a cost-effectiveness perspective. Preventative Medicine in Managed Care 2000;1(Suppl 1):S42-S51.
Arbo MD, Snydman DR, Wong JB, Goldberg HS, Schmid CH, Pauker SG.Cytomegalovirus immune globulin after liver transplantation: a cost-effectiveness analysis. Clinical Transplantation. 2000;14(1):19-27.
Beck JR, Pauker SG.Does DEALE-ing stack the deck? [editorial]. Medical Decision Making. 1999;19(4):503-4.
Orr RK, Col NF, Kuntz KM.A cost-effectiveness analysis of axillary node dissection in postmenopausal women with estrogen receptor-positive breast cancer and clinically negative axillary nodes. Surgery. 1999;126(3):568-76.
Col NF, Pauker SG, Goldberg RJ, Eckman MH, Orr RK, Ross EM, et al.individualizing therapy to prevent long-term consequences of estrogen deficiency in postmenopausal women. Archives of Internal Medicine. 1999;159(13):1458-66.
Orr RK, Hoehn JL, Col NF.The learning curve for sentinel node biopsy in breast cancer: practical considerations. Archives of Surgery. 1999;134(7):764-7.
Wong JB.Cost-effectiveness of treatments for chronic hepatitis C. American Journal of Medicine. 1999;107(6B):74S-78S.
Engels EA, Ellis CA, Supran SE, Schmid CH, Barza M, Schenkein DP, et al.Early infection in bone marrow transplantation: quantitative study of clinical factors that affect risk. Clinical Infectious Diseases. 1999;28(2):256-66.
Santoro NF, Col NF, Eckman MH, Wong JB, Pauker SG, Cauley JA, et al.Therapeutic controversy: Hormone replacement therapy--where are we going? Journal of Clinical Endocrinology & Metabolism. 1999;84(6):1798-812.
Ross EM, Rosenberg IH, Dawson-Hughes B, Col NF, Wong JB.Fitting nutrition into the medical model: the role of decision analytic cost-effectiveness techniques. European Journal of Clinical Nutrition. 1999;53(Suppl 2):S25-8.
Kopelman RI, Wong JB, Pauker SG.Clinical problem-solving. A little math helps the medicine go down. New England Journal of Medicine. 1999;341(6):435-9.
Provenzale D, Schmitt C, Wong JB.Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk. American Journal of Gastroenterology. 1999;94(8):2043-53.
Pauker SG, Eckman MH.Finding what you seek: analyzing therapies for nonvalvular atrial fibrillation [editorial; comment]. Annals of Internal Medicine. 1999;130(8):690-1.
Pauker SG, Rothberg M.Commentary: resist jumping to conclusions. Bmj. 1999;318(7198):1616-7.
Lilford RJ, Pauker SG, Braunholtz DA, Chard J.Decision analysis and the implementation of research findings. Bmj. 1998;317(7155):405-9.
Eckman MH, Levine HJ, Salem DN, Pauker SG.Making decisions about antithrombotic therapy in heart disease: decision analytic and cost-effectiveness issues. Chest. 1998;114(5 Suppl):699S-714S.
Wong JB.Interferon treatment for chronic hepatitis B or C infection: costs and effectiveness. Acta Gastroenterologica Belgica. 1998;61(2):238-42.
Eckman MH, Falk RH, Pauker SG.Cost-effectiveness of therapies for patients with nonvalvular atrial fibrillation. Archives of Internal Medicine. 1998;158(15):1669-77.
Provenzale D, Wong JB, Onken JE, Lipscomb J.Performing a cost-effectiveness analysis: surveillance of patients with ulcerative colitis. American Journal of Gastroenterology. 1998;93(6):872-80.
Pauker SG, Pauker SP.Expected-utility perspectives on defensive testing. Torts, tradeoffs, and thresholds--is defensive medicine defensible? [comment]. Medical Decision Making. 1998;18(1):29-31.
Wong JB, Bennett WG, Koff RS, Pauker SG.Pretreatment evaluation of chronic hepatitis C: risks, benefits, and costs. Jama. 1998;280(24):2088-93.
Eckman MH, Levine HJ, Salem DN, Pauker SG.Making decisions about antithrombotic therapy in heart disease: Decision analytic and cost effectiveness issues. Chest 1998;114(5 Suppl):699S-714S.
Salem DN, Levine HJ, Pauker SG, Eckman MH, Daudelin DH.Antithrombotic therapy in valvular heart disease. Chest. 1998;114(5 Suppl):590S-601S.
Cook DJ, Guyatt GH, Pauker SG, Eckman MH, Sackett DL.Clinical recommendations using levels of evidence for antithrombotic agents. Chest 1998;114(5 Suppl):441S-444S.
Eckman MH, Steere AC, Kalish RA, Pauker SG.Cost effectiveness of oral as compared with intravenous antibiotic therapy for patients with early Lyme disease or Lyme arthritis. New England Journal of Medicine. 1997;337(5):357-63.
Helfand M, Pauker SG.Influence diagrams: a new dimension for decision models [editorial]. Medical Decision Making. 1997;17(3):351-2.
Litvak E, Siegel JE, Pauker SG, Lallemant M, Fineberg HV, Weinstein MC.Whose blood is safer? The effect of the stage of the epidemic on screening for HIV. Medical Decision Making. 1997;17(4):455-63.
Epstein SK, Ciubotaru RL, Wong JB.Effect of failed extubation on the outcome of mechanical ventilation. Chest. 1997;112(1):186-92.
Col NF, Eckman MH, Karas RH, Pauker SG, Goldberg RJ, Ross EM, et al.Patient-specific decisions about hormone replacement therapy in postmenopausal women. Jama. 1997;277(14):1140-7.
Pauker SG, Stahl JE.Medical informatics: where the action is [editorial]. Western Journal of Medicine. 1997;166(2):148-50.
Pauker SG, Kassirer JP.Contentious screening decisions: does the choice matter? [editorial]. New England Journal of Medicine. 1997;336(17):1243-4.
Bennett WG, Inoue Y, Beck JR, Wong JB, Pauker SG, Davis GL.Estimates of the cost-effectiveness of a single course of interferon-alpha 2b in patients with histologically mild chronic hepatitis C. Annals of Internal Medicine. 1997;127(10):855-65.
Suggestions should be sent to jwong@tuftsmedicalcenter.org